Magnetic resonance spectroscopic studies of the prostate

Molecular Urology

Volumn 4, Issue 3, 2000, Pages 143-153

  Koutcher, J A ^a   Zakian, K ^a   Hricak, H ^a   Garnick, M ^a   Stone, N ^a   Debruyne, F ^a   Moul, J ^a  

^a MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CONFERENCE PAPER; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; DIAGNOSTIC VALUE; HUMAN; MAJOR CLINICAL STUDY; MALE; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY; PRIORITY JOURNAL; PROSTATE CANCER; PROSTATE HYPERTROPHY; THEORY;

ADENOCARCINOMA; CHOLINE; CITRIC ACID; HUMANS; MAGNETIC RESONANCE SPECTROSCOPY; MALE; NEOPLASM STAGING; PROSTATE; PROSTATIC NEOPLASMS;

EID: 0033756128     PISSN: 10915362     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (76)

1. Tumor detection by nuclear magnetic resonance
2. Image formation by induced local interactions: Examples employing nuclear magnetic resonance
3. Simultaneous 3D NMR spectroscopy of proton-decoupled fluorine and phosphorus in human liver during 5-fluorouracil chemotherapy
4. In vivo 13C NMR spectroscopy of the human prostate
5. 31P MR spectroscopy and 1H MR imaging of the human prostate using a transrectral probe
6. 31P spectroscopy of the human prostate gland in vivo using a transrectal probe
7. 31phosphorus magnetic resonance spectroscopy: A preliminary report
8. Differentiation of human tumors from nonmalignant tissue by natural-abundance 13C NMR spectroscopy
9. The prostate secretion
10. The physiology of the prostate gland
11. Citric acid in human prostate secretion and metastasizing cancer of the prostate gland
12. The role of citric acid in the physiology of the prostate. A chromatographic study of the citric acid cycle inter-mediates in benign and malignant prostatatic tissue
13. The role of citric acid in the physiology of the prostate III: Lactate/citrate ratios in benign and malignant prostatic homogenates as an index of prostatic malignancy
14. Concepts of citrate production and secretion by prostate 1: Metabolic relationship
15. Concepts of citrate production and secretion by prostate 2: Hormonal relationship in normal and neoplastic prostate
16. Regulation of citrate metabolism in normal and neoplastic prostate
17. Bioenergetic theory of prostate malignancy
18. Aconitase activity, citrate oxidation, and zinc inhibition in rat ventral prostate
19. Membrane structural dynamics of plasma membranes of living human prostatic carcinoma cells differing in metastatic potential
20. Composition and fatty acid content of rat ventral prostate phospholipids
21. Alterations in sphingomyelin and fatty acids in human benign prostatic hyperplasia and prostatic cancer
22. Biochemical, cytogenetic, and morphological characteristics of human primary and metastatic prostate cancer cell lines
23. Morphometric and clinical studies on 68 consecutive radical prostatectomies
24. The prostate gland: Morphology and pathobiology
25. 1H magnetic resonance spectroscopy and biochemical study
26. Citrate as an in vivo marker to discriminate prostate cancer from benign prostatic hyperplasia and normal prostate peripheral zone. Detection via localized proton spectroscopy
27. Prostate cancer: Localization with three-dimensional proton MR spectroscopic imaging: Clinicopathologic study
28. 1H NMR
29. 1H spectroscopy of the human prostate: Benign prostatic hyperplasia, normal peripheral zone and adenocarcinoma
30. 31P magnetic resonance spectroscopy
31. Magnetic resonance spectroscopy detects metabolic differences between seven Dunning rat prostate tumor sublines with different biological behavior
32. In vitro proton magnetic resonance spectroscopy of four human prostate cancer cell lines
33. 23Na MR imaging
34. Local staging of prostate cancer with endorectal coil MRI: Correlation with whole mount radical prostatectomy specimens
35. Carcinoma of the prostate gland: MR imaging with phased array coils versus integrated endorectal-pelvic phased array coils
36. Prostate carcinoma: Assessment of diagnostic criteria for capsular penetration on endorectal coil MR images
37. Comparison of magnetic resonance imaging and ultrasonography in staging early prostate cancer: Results of a multi-institutional cooperative trial
38. Prostatic carcinoma and benign prostatic hyperplasia: Correlation of high resolution MR and histopathologic findings
39. Transrectal ultrasound vs digital rectal examination for the staging of carcinoma of the prostate. Results of a prospective multi-institutional trial
40. 3) spatial resolution
41. Localized high resolution 1H NMR spectroscopy using stimulated echoes: Initial applications to human brain in vivo
42. NMR chemical shift imaging in three dimensions
43. Studies of human tumors by MRS: A review
44. Magnetic resonance spectroscopy of tumors and potential in vivo clinical applications: A review
45. 31P nuclear magnetic resonance spectroscopy are not correlated with chronic nutrient deficiency in multicellular tumor spheroids
46. 31P NMR analyses of phosphocholine metabolism in rat glioma cells
47. Phosphomonoesters and growth fraction in multicellular spheroids
48. Serial proton magnetic resonance spectroscopy imaging of glioblastoma multiforme after brachytherapy
49. 1H MR spectroscopic imaging: Clinical relevance
50. 1H spectroscopy of inoperable brain gliomas: Response to radiation therapy
51. Mapping of brain tumor metabolites with proton MR spectroscopic imaging: Clinical relevance
52. Human brain tumors: Spectral patterns detected with localized H-1 MR spectroscopy
53. Accurate, noninvasive diagnosis of human brain tumors by using proton magnetic resonance spectroscopy
54. 1H MR spectroscopy in patients with metastatic brain tumors: A multicenter study
55. Efficacy of proton magnetic resonance spectroscopy in clinical decision making for patients with suspected malignant brain tumors
56. 1H MR spectroscopy - Initial results
57. Detection of locally recurrent prostate cancer after cryosurgery: Evaluation by transrectal ultrasound, magnetic resonance imaging, and three-dimensional proton magnetic resonance spectroscopy
58. Prostate cancer: Metabolic response to cryosurgery as detected with 3D H-1 MR spectroscopic imaging
59. Localizing prostate cancer in the presence of postbiopsy changes in MR images: Role of proton MR spectroscopic imaging
60. Prostate cancer: Prediction of extracapsular extension with endorectal MR imaging and three-dimensional proton MR spectroscopic imaging
61. Prostate cancer: Localization with three-dimensional proton MR spectroscopic imaging - Clinicopathologic study
62. In vivo proton magnetic resonance spectroscopy of diseased prostate: Spectroscopic features of malignant versus benign pathology
63. In vivo magnetic resonance spectroscopy and dynamic contrast enhanced imaging of the prostate gland
64. 1H MRS and MRI
65. In vivo proton MR spectroscopy reveals altered metabolite content in malignant prostate tissue
66. Proton MR spectroscopy of the normal human prostate with and endorectal coil and a double spin-echo pulse sequence
67. In vivo differential diagnosis of prostate cancer and benign prostatic hyperplasia: Localized proton magnetic resonance spectroscopy using external body surface coil
68. Human prostate: Multisection proton MR spectroscopic imaging with a single spin-echo sequence - Preliminary experience
69. 1H NMR chemical shift selective (CHESS) imaging
70. Improved solvent suppression and increased spatial excitation bandwidths for three-dimensional PRESS CSI using phase-compensating spectral/spatial spin-echo pulses
71. 1H magnetic resonance spectroscopic imaging
72. Very selective suppression pulses for clinical MRSI studies of brain and prostate cancer
73. Prostate cancer: Effect of postbiopsy hemorrhage on interpretation of MR images
74. Static field intensity modulation to treat a dominant intra-prostatic lesion to 90 Gy compared to seven field 3-dimensional radiotherapy
75. Intensity modulated conformal treatment planning for prostate implants using MR spectroscopy imaging